Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Calcium chloride + sodium lactate + magnesium chloride + sodium chloride + dextrose monohydrate** is a multi-ingredient **peritoneal dialysis solution** used for intraperitoneal dialysis in patients with acute or chronic renal failure, including chronic kidney failure. It is a sterile electrolyte and osmotic agent formulation in which dextrose monohydrate provides the osmotic driving force for ultrafiltration, while sodium, calcium, magnesium, chloride, and lactate help maintain acid-base and electrolyte balance during dialysis. The solution acts locally across the **peritoneal membrane**, which serves as the semipermeable dialysis interface for removal of water and uremic solutes. Public context provided identifies the marketed product **DIANEAL LOW CALCIUM WITH DEXTROSE**, with manufacturing/distribution associated with **Vantive** and **Baxter**.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium chloride + sodium lactate + magnesium chloride + sodium chloride + dextrose monohydrate.